Better Buy to Beat the TSX: Canada Goose Holdings Inc. or MedReleaf Corp.?

Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS) and MedReleaf Corp. (TSX:LEAF) have throttled the TSX since being listed in 2017.

| More on:
The Motley Fool

The S&P/TSX Composite Index rose 11 points on April 12. The index has dropped 5.8% in 2018 thus far. The TSX was one of the worst-performing global exchanges in the first quarter. It has been a frustrating start to the year for the Canadian investor, and industry leaders are now warning that Canada is suffering from a bout of capital flight in the aftermath of United States tax reform.

Trade tensions and the threat of rising interest rates are enough to keep analysts anxious looking ahead. However, there are still attractive plays on the TSX and stocks could receive a boost if NAFTA negotiations move towards a new agreement in the near term, as is expected. Let’s look at two stocks today that have suffered from volatility since late January. Which should you buy?

Canada Goose Holdings Inc. (TSX:GOOS)(NYSE:GOOS)

Canada Goose is a Toronto-based outerwear designer, manufacturer, and retailer. Shares of Canada Goose have climbed 9.9% in 2018 as of close on April 12. However, since rebounding from a sharp drop after its fiscal 2018 Q3 results, Canada Goose stock has failed to reach its previous highs. Can it still offer the kind of explosive growth we saw in the second half of 2017?

Canada Goose released its fiscal 2018 third-quarter results on February 8. Revenue rose 27.2% year over year to $265.8 million, and adjusted EBITDA climbed 43.2% to $94.7 million. Wholesale revenue actually declined year over year, but growth was driven by remarkable numbers in direct-to-consumer revenue. The company opened seven new e-commerce sites, and revenue rose to $131.6 million compared to $72 million in the prior year.

Shares dropped in spite of these impressive earnings after the company failed to produce an annual outlook, and CEO Dani Reiss initially said the company did not plan to ramp up production in response to dwindling supply. However, in March, Canada Goose announced that it plans more in-house production in order to meet demand and increase profit going forward. The stock is up 3% month over month.

MedReleaf Corp. (TSX:LEAF)

MedReleaf is a Markham-based cannabis producer. Shares of MedReleaf rose 9.88% on April 12, but the stock has plunged 13% in 2018 so far, as cannabis stocks have been battered. MedReleaf released its fiscal 2018 third-quarter results on February 13.

Total sales rose to $11.3 million compared to $10.4 million, and gross profit increased to $9.98 million in comparison to $9.71 million in the prior year. Total grams sold were over 1.2 million compared to 993,259 in Q3 fiscal 2017. It was also a busy quarter, as MedReleaf signed an agreement to become a medical cannabis supplier for Shoppers Drug Mart and was granted a licence for the cultivation and production of medical cannabis from the Australian government.

Which stock should you buy today?

Canada Goose is entering its slow season, but its decision to ramp up production is promising. MedReleaf stock is up 15.4% week over week, and the cannabis market appears to be stabilizing after top producers have suffered steep corrections. At its current valuation, MedReleaf represents one of the best deals in the sector, and I like it to outperform Canada Goose from here on out.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned.

More on Investing

A bull and bear face off.
Energy Stocks

Dividend Investors: Top Canadian Energy Stocks for November

These three dividend-payers are on a bullish uptrend.

Read more »

Hourglass and stock price chart
Dividend Stocks

Where Will Brookfield Stock Be in 5 Years?

Based on its recent successes, Brookfield Corp (TSX:BN) looks poised to be more valuable in five years' time than today.

Read more »

Canada day banner background design of flag
Retirement

RRSP Wealth: 2 Great Canadian Dividend Stocks to Buy in November

Investors in these stocks have received annual dividend increases for decades.

Read more »

stocks climbing green bull market
Tech Stocks

Why Propel Stock Keeps Going Up

Propel stock has seen a fivefold increase in its market cap in the last year! But even more is set…

Read more »

ways to boost income
Dividend Stocks

This Top TSX Dividend Stock Down 10.78% Is Ready for a Rebound

The rebound of an underperforming but top TSX dividend stock is coming due to a significant product diversification.

Read more »

hand stacks coins
Dividend Stocks

The Smartest Dividend Stocks to Buy With $400 Right Now

The market is full of dividend stocks to buy. Here's a look at two options that cater to both growth…

Read more »

Canadian Dollars bills
Dividend Stocks

3 Dividend Stocks to Supercharge Your Passive Income

These companies are known for their consistent payout histories and high yields can supercharge your passive-income portfolio.

Read more »

space ship model takes off
Top TSX Stocks

My 5 Favourite Stocks to Buy Right Now

There are plenty of great stocks on the market. Here's a look at my favourite stocks to own for growth…

Read more »